Skip to main content
Premium Trial:

Request an Annual Quote

Jay Flatley

Illumina CEO Jay Flatley has been elected chairman of the firm's board of directors following the resignation of William Rastetter, who served as chairman for the past 11 years. Rastetter resigned the post so he could invest in and serve as an Illumina representative on the board of directors of Grail, a majority-owned subsidiary of Illumina launched last month. Illumina said that its board intends to appoint a lead independent director.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.